Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

NicOx Announces Second Naproxcinod Pivotal Phase 3 Study (302) Meets Efficacy Primary Endpoints and Supports Non-Detrimental Blood Pressure Effect
Genetic Engineering News
Monday, September 15, 2008 - 11:00am
tags:
Le Fur Flies: Sanofi CEO To Get Big Payout
Pharmalot
Monday, September 15, 2008 - 10:59am
tags:
BMS gets closer to Accenture with $550m IT deal
Outsourcing Pharma
Monday, September 15, 2008 - 10:59am
tags:
Doctors wary of drug makers
Ft Wayne Journal Gazette, TX
Monday, September 15, 2008 - 10:58am
tags:
FDA says won't OK expanded use of Fentora pain drug unless Cephalon boosts risk management
Yahoo/AP
Monday, September 15, 2008 - 10:50am
tags:
FDA Grants Approval to Talecris Biotherapeutics for Gamunex(R) as a Treatment for Neurological Disorder CIDP in the United States
Earth Times
Monday, September 15, 2008 - 10:49am
tags:
Is Cypress Bioscience Poised to Move Ahead?
Seeking Alpha
Monday, September 15, 2008 - 10:42am
tags:
Mann Bets $1 Billion on Inhaled Insulin Pfizer Dumped
Bloomberg
Monday, September 15, 2008 - 10:40am
tags:
Amgen Hopes New Bone Drug Will Strengthen Shares
WSJ Online
Monday, September 15, 2008 - 10:39am
tags:
Drug stocks follow broader market into red
Marketwatch
Monday, September 15, 2008 - 10:38am
tags:
Older Antipsychotics May Be Better Option for Troubled Kids
WSJ Online
Monday, September 15, 2008 - 10:37am
tags:
Carl Icahn increases ownership stake in Amylin Pharmaceuticals to 7.3 percent
Yahoo/AP
Monday, September 15, 2008 - 8:53am
tags:
Antigenics to Present on Unique Cancer Therapy
Cafepharma Detailpiece
Monday, September 15, 2008 - 8:51am
tags:
Ownership of Erbitux Follow-On Is Central to ImClone Takeover
Seeking Alpha
Sunday, September 14, 2008 - 12:28pm
tags:
Bristol-Meyers Squibb vs. Imclone: Icahn Stirs Up the Pot
Seeking Alpha
Sunday, September 14, 2008 - 12:26pm
tags:
CV Therapeutics to get up to $315M for Ranexa licensing
Washington Business Journal, DC
Sunday, September 14, 2008 - 12:25pm
tags:
Expiring Patents Ignite Biotech Boom
Seeking Alpha
Sunday, September 14, 2008 - 12:23pm
tags:
Sun Pharmaceuticals gets USFDA nods for Alendronate Sodium tablets
Stock Watch, India
Sunday, September 14, 2008 - 12:22pm
tags:
Biopharma business sets up one-stop-shop online
Sunday Business Post, Ireland
Sunday, September 14, 2008 - 12:20pm
tags:
Go East, young biomed company
Globes, Israel
Sunday, September 14, 2008 - 12:08pm
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.